Back to Search

TODD VANDENBERG, MD

MD

Urology Physician

NPI: 1558367623IndividualAccepts Medicare

Specialties, Licenses & Credentials

Urology PhysicianPrimary

Urology

Code: 208800000X

20877(SC)

CMS Specialties

PrimaryUROLOGY

Education

TULANE UNIVERSITY SCHOOL OF MEDICINE

Class of 1993

Research & Publications (11)

A framework for the organization and delivery of systemic treatment.
PMID 19229367·Curr Oncol·2009
8-other
A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12).
PMID 19628570·Ann Oncol·2010
2-rct
Phase II trial of OGX-011 in combination with docetaxel in metastatic breast cancer.
PMID 19147778·Clin Cancer Res·2009
3-trial
Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer.
PMID 18437556·Breast Cancer Res Treat·2009
8-other
A Phase 2 study of perifosine in advanced or metastatic breast cancer.
PMID 17458693·Breast Cancer Res Treat·2008
3-trial
Serial plasma osteopontin levels have prognostic value in metastatic breast cancer.
PMID 16740755·Clin Cancer Res·2006
8-other
A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer.
PMID 15888383·Bull Cancer·2005
6-review
A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group trial, IND 129.
PMID 12649098·Ann Oncol·2003
3-trial
Caution with breast-conserving surgery.
PMID 12427689·CMAJ·2002
8-other
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues.
PMID 12202679·J Clin Oncol·2002
8-other
Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8.
PMID 10856098·J Clin Oncol·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
114 Gateway Corporate Blvd Ste 210
Columbia, SC 29203

Locations (2)

Practice Location

114 Gateway Corporate Blvd Ste 210, Columbia, SC
(803) 365-8620

Practice Location

222 E MEDICAL LN STE 101, WEST COLUMBIA, SC
(803) 739-3660

Quick Facts

NPI
1558367623
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
2
Years in Practice
33
Publications
11

Are you this provider?

Claim Your Profile